Recurrent Gastric Cancer Completed Phase 2 Trials for Alvocidib (DB03496)

Also known as: Gastric cancer recurrent / Stomach cancer recurrent / Stomach carcinoma recurrent / Gastric carcinoma recurrent

DBCOND0028800 (Recurrent Gastric Cancer)Completed2 IdentifierTitlePurposeDrugs
NCT00991952Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By SurgeryTreatment